Merck & Co., Inc.

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 12Value: $164.3MLatest: 2025Q1

Merck & Co., Inc. is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 12 holdings worth $0.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "PSNL",
  "KYMR",
  "ALEC",
  "CARM",
  "LVTX",
  "STRO",
  null,
  null,
  null,
  "MRNA",
  "VRDN",
  "XLO"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 12
Total Value: 164284061
Accession Number: 0000064978-25-000005
Form Type: 13F-HR
CIK: merck--co
Manager Name: Merck--Co

Data Enrichment

75% identified

9 identified3 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

12 positions • $164.3M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

Moderna, Inc.

MRNA|60770K107

Shares:2.3M

Value:$65.4M

% of Portfolio:39.8% ($65.4M/$164.3M)

Personalis, Inc.

PSNL|71535D106

Shares:14.0M

Value:$49.3M

% of Portfolio:30.0% ($49.3M/$164.3M)

Kymera Therapeutics, Inc.

KYMR|501575104

Shares:772.2K

Value:$21.1M

% of Portfolio:12.9% ($21.1M/$164.3M)

29384C908

Shares:1.7M

Value:$15.7M

% of Portfolio:9.6% ($15.7M/$164.3M)

Alector, Inc.

ALEC|014442107

Shares:3.5M

Value:$4.4M

% of Portfolio:2.7% ($4.4M/$164.3M)

29970R204

Shares:1.2M

Value:$2.2M

% of Portfolio:1.4% ($2.2M/$164.3M)

SUTRO BIOPHARMA, INC.

STRO|869367102

Shares:2.7M

Value:$1.8M

% of Portfolio:1.1% ($1.8M/$164.3M)

LAVA Therapeutics NV

LVTX|N51517105

Shares:1.1M

Value:$1.5M

% of Portfolio:0.9% ($1.5M/$164.3M)

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:93.4K

Value:$1.3M

% of Portfolio:0.8% ($1.3M/$164.3M)

Xilio Therapeutics, Inc.

XLO|98422T100

Shares:1.5M

Value:$1.1M

% of Portfolio:0.7% ($1.1M/$164.3M)

Carisma Therapeutics Inc.

CARM|14216R101

Shares:1.5M

Value:$456.7K

% of Portfolio:0.3% ($456.7K/$164.3M)

64136E102

Shares:10.0K

Value:$57.8K

% of Portfolio:0.0% ($57.8K/$164.3M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Moderna, Inc.(MRNAcusip60770K107)	2.3M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$65.4M	39.8% ($65.4M/$164.3M)	QoQ -31.81% (-$30.5M) YoY-
Personalis, Inc.(PSNLcusip71535D106)	14.0M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$49.3M	30.0% ($49.3M/$164.3M)	QoQ -39.27% (-$31.9M) YoY-
Kymera Therapeutics, Inc.(KYMRcusip501575104)	772.2K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$21.1M	12.9% ($21.1M/$164.3M)	QoQ -31.96% (-$9.9M) YoY-
(cusip29384C908)✕	1.7M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$15.7M	9.6% ($15.7M/$164.3M)	QoQ -47.71% (-$14.4M) YoY-
Alector, Inc.(ALECcusip014442107)	3.5M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$4.4M	2.7% ($4.4M/$164.3M)	QoQ -34.92% (-$2.3M) YoY-
(cusip29970R204)✕	1.2M	QoQ +123.89% (+671.8K) YoY-	All Managers (Combined)	$2.2M	1.4% ($2.2M/$164.3M)	QoQ +389.94% (+$1.8M) YoY-
SUTRO BIOPHARMA, INC.(STROcusip869367102)	2.7M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.8M	1.1% ($1.8M/$164.3M)	QoQ -64.64% (-$3.2M) YoY-
LAVA Therapeutics NV(LVTXcusipN51517105)	1.1M	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$1.5M	0.9% ($1.5M/$164.3M)	QoQ +33.54% (+$366.6K) YoY-
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	93.4K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.3M	0.8% ($1.3M/$164.3M)	QoQ -29.68% (-$531.5K) YoY-
Xilio Therapeutics, Inc.(XLOcusip98422T100)	1.5M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.1M	0.7% ($1.1M/$164.3M)	QoQ -24.14% (-$342.2K) YoY-
Carisma Therapeutics Inc.(CARMcusip14216R101)	1.5M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$456.7K	0.3% ($456.7K/$164.3M)	QoQ -25.97% (-$160.3K) YoY-
(cusip64136E102)✕	10.0K	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$57.8K	0.0% ($57.8K/$164.3M)	QoQ +67.92% (+$23.4K) YoY-